Edition:
United Kingdom

HBM Healthcare Investments AG (HBMN.S)

HBMN.S on Swiss Exchange

162.00CHF
21 Jun 2018
Change (% chg)

CHF-0.60 (-0.37%)
Prev Close
CHF162.60
Open
CHF162.60
Day's High
CHF162.60
Day's Low
CHF161.00
Volume
4,271
Avg. Vol
8,849
52-wk High
CHF169.60
52-wk Low
CHF110.50

Chart for

About

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer... (more)

Overall

Beta: 0.49
Market Cap(Mil.): CHF838.46
Shares Outstanding(Mil.): 7.04
Dividend: 5.80
Yield (%): 4.87

Financials

  HBMN.S Industry Sector
P/E (TTM): 10.87 127.59 20.18
EPS (TTM): 10.95 -- --
ROI: 8.26 6.23 0.48
ROE: 9.11 11.38 15.39

BRIEF-HBM Healthcare Investments FY Net Profit Of Around CHF 115 Million

* SAID ON TUESDAY EXPECTED FY NET PROFIT OF AROUND CHF 115 MILLION

04 Apr 2018

BRIEF-HBM Healthcare Investments 9-Mth Profit At CHF 85.6 Mln

* PROFIT FOR THE FIRST NINE MONTHS OF THE 2017/2018 FINANCIAL YEAR AT A TOTAL OF CHF 85.6 MILLION

25 Jan 2018

BRIEF-HBM Healthcare Investments Expects Profit Of Over CHF 85 Million For First 9 Months Of 2017/2018‍​

* FOR FIRST NINE MONTHS OF 2017/2018, EXPECTS A PROFIT OF OVER CHF 85 MILLION‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

03 Jan 2018

Earnings vs. Estimates